BMY Financial Facts
Net Earnings Attributable to Noncontrolling Interest: 13MMarketing, selling and administrative: 1.14B
See Full Income Statement
Capital in excess of par value of stock: 1.65B
Other intangible assets: 1.38B
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
| Next EPS Date | 7/25/24 *Est. | EPS Growth Rate | -314.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +5.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/11  |
 |
Q410 | $0.47 | $0.48 | -$0.01 | $5.1B | $5.04B | = |  | | Details |
| 10/26/10 |
|
Q310 | $0.59 | $0.53 | +$0.06 | N/A | N/A | N/A | | | Details |
| 10/24/14 |
|
Q314 | $0.45 | $0.42 | +$0.03 | $3.92B | $3.8B |  |
| | Details |
| 10/23/13 |
|
Q313 | $0.46 | $0.44 | +$0.02 | $4.07B | $4.02B | = | | | Details |
| 10/25/22 | Q322 | $1.99 | $0.00 | +$1.99 | $11.22B | N/A | = | | | Details | |
| 7/25/19 | |
Q219 | $1.18 | $1.06 | +$0.12 | $6.3B | $6.11B | |
| | Details |
| 1/24/13 |
|
Q412 | $0.47 | $0.42 | +$0.05 | $4.19B | $4.14B | = | | | Details |
| 2/4/22 | |
Q421 | $1.83 | $1.82 | +$0.01 | $12B | $12.12B | = | | | Details |
